Shopping Cart
- Remove All
- Your shopping cart is currently empty
DSP5336, an oral small-molecule inhibitor, targets the interaction between menin and MLL proteins. It is currently undergoing clinical evaluation for its potential use in treating patients with relapsed or refractory acute leukemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | DSP5336, an oral small-molecule inhibitor, targets the interaction between menin and MLL proteins. It is currently undergoing clinical evaluation for its potential use in treating patients with relapsed or refractory acute leukemia. |
Molecular Weight | 419.40 |
Formula | C20H20F3N5O2 |
Cas No. | 2512197-69-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.